GCM
ADAP

Graham Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Graham Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-87,274
Closed -$17.2K – 1227
2025
Q1 		$17.2K Buy
87,274
+50,079
+135% +$9.87K ﹤0.01% 1215
2024
Q4 		$20K Buy
37,195
+24,603
+195% +$13.3K ﹤0.01% 1170
2024
Q3 		$12K Buy
+12,592
New +$12K ﹤0.01% 1030